We are live on ! Find out more
ALT icon

Altimmune
ALT

110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

647% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.75M

600% more funds holding in top 10

Funds holding in top 10: 1 → 7 (+6)

125% more capital invested

Capital invested by funds: $207M → $467M (+$260M)

27% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 30

14.47% more ownership

Funds ownership: 77.86% → 92.33% (+14%)

7% more funds holding

Funds holding: 103 → 110 (+7)

13% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 31

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.85%
Holding in Top 10
7
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+600%
% of All Funds
0.12%
New
38
Increased
27
Reduced
31
Closed
30
Calls
$13.1M
Puts
$1.75M
Net Calls
+$11.4M
Net Calls Change
+$6.91M

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$18.5M
2
TCM
Tang Capital Management
California
+$6.33M
3
BBA
Baker Bros. Advisors
New York
+$6.19M
4
DCM
Driehaus Capital Management
Illinois
+$5.8M
5
IC
Ikarian Capital
Texas
+$5.53M

Top Sellers

1
BlackRock
BlackRock
New York
-$12.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.92M
3
State Street
State Street
Massachusetts
-$3.43M
4
VA
VR Adviser
New York
-$2.41M
5
WP
Woodline Partners
California
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
$42.1M +$6.33M +1,026,706 +40%
N
2
Nuveen
North Carolina
$35.9M -$1.12M -180,924 -6%
CAM
3
Cormorant Asset Management
Massachusetts
$35.1M +$18.5M +3,000,000 New
APM
4
Avidity Partners Management
Texas
$34.9M +$715K +116,000 +4%
BBA
5
Baker Bros. Advisors
New York
$24.3M +$6.19M +1,003,365 +94%
Vanguard Group
6
Vanguard Group
Pennsylvania
$20.2M -$563K -91,369 -5%
SFM
7
Sphera Funds Management
Israel
$16.3M +$530K +85,931 +7%
Morgan Stanley
8
Morgan Stanley
New York
$16.1M -$209K -33,915 -2%
AAP
9
Ardsley Advisory Partners
Connecticut
$15.7M -$86.3K -14,000 -1%
Citadel Advisors
10
Citadel Advisors
Florida
$13.4M +$145K +23,451 +2%
Barclays
11
Barclays
United Kingdom
$12.5M -$553K -89,734 -8%
BlackRock
12
BlackRock
New York
$11.3M -$12.2M -1,974,140 -67%
DCM
13
Driehaus Capital Management
Illinois
$11M +$5.8M +940,061 New
IC
14
Ikarian Capital
Texas
$10.5M +$5.53M +897,359 New
Citigroup
15
Citigroup
New York
$10.4M +$613K +99,343 +13%
Millennium Management
16
Millennium Management
New York
$9.65M +$786K +127,488 +18%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$8.97M +$467K +75,800 +11%
LCM
18
Laurion Capital Management
New York
$8.94M +$4.71M +763,970 New
Renaissance Technologies
19
Renaissance Technologies
New York
$7.79M +$1.71M +276,700 +71%
Two Sigma Investments
20
Two Sigma Investments
New York
$7.2M +$69.1K +11,198 +2%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$7.13M +$3.76M +609,100 New
TLP
22
Tri Locum Partners
New York
$6.72M +$3.54M +574,646 New
PHP
23
Parkman Healthcare Partners
Connecticut
$6.55M +$1.54M +250,169 +81%
WP
24
Woodline Partners
California
$6.44M -$1.82M -295,933 -35%
Goldman Sachs
25
Goldman Sachs
New York
$5.91M -$1.38M -224,113 -31%
1
2 3 4 5

ALT Hedge Fund Activity: Q2 2022 in Review

110 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2022, worth a combined $467M — up 125% from $207M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ALT positions and 30 closed out — a net gain of 8 holders — while 27 added to existing stakes and 31 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $18.5M. The largest seller was BlackRock, cutting an estimated $12.2M.

  • 110 institutional investors held Altimmune (ALT) as of Q2 2022, up from 103 in Q1 2022.
  • Funds reported $467M of Altimmune stock for Q2 2022, up 125% quarter-over-quarter.
  • 38 funds opened new Altimmune positions in Q2 2022 and 30 closed out, a net change of +8 holders.
  • The largest Altimmune buyer in Q2 2022 was Cormorant Asset Management, an estimated $18.5M added.
  • The largest Altimmune seller in Q2 2022 was BlackRock, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2022.